Pricing database updated July 12, 2026Methodology v1.0How we score →
Compare Providers
Home / Peptides / CJC-1295 / Ipamorelin
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Written by Dr. Parmis Mojarab, DO·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

CJC-1295 / Ipamorelin: evidence, legality and safety

Quick answer

CJC-1295 and ipamorelin are frequently marketed together as a growth-hormone-releasing stack. Neither is an FDA-approved finished consumer drug, and human outcome evidence for the combined protocol is limited. The pairing is a marketing convention, not an approved regimen.

Regulatory statusNot FDA-approved as a finished consumer drug.

What the evidence shows

CJC-1295 and ipamorelin are frequently marketed together as a growth-hormone-releasing stack. Neither is an FDA-approved finished consumer drug, and human outcome evidence for the combined protocol is limited. The pairing is a marketing convention, not an approved regimen.

Human clinical evidence

No adequate combined-protocol outcome trials in humans.

Animal and laboratory evidence

Individual components show GH release preclinically; the combination's incremental benefit is not established. We keep animal and laboratory findings clearly separated from human evidence, because preclinical results routinely fail to translate to people.

Known and potential risks

Combined GH-axis stimulation, unregulated sourcing, unknown long-term safety.

No consumer dosing for research compoundsThis page does not provide dosing instructions for unapproved compounds, and we do not link to research-chemical sellers. If you are considering peptide therapy, do it through a licensed clinician who can weigh your individual risks.

The lawful pathway for any prescription peptide is a licensed clinician and a licensed pharmacy. Products labeled "for research use only" are not lawfully sold for human consumption. See how to verify a peptide provider and research peptides versus prescription therapy.

Status in sport

Both components are prohibited under anti-doping codes.

Frequently asked questions

Is CJC-1295 / Ipamorelin FDA-approved?

Not FDA-approved as a finished consumer drug.

Is there human evidence for CJC-1295 / Ipamorelin?

No adequate combined-protocol outcome trials in humans.

Is CJC-1295 / Ipamorelin legal to buy?

Many peptides in this category are sold as 'research chemicals,' which is not a lawful pathway for human use. Legitimacy depends on approval status and whether a licensed clinician and pharmacy are involved. We do not link to research-chemical sellers.

Is CJC-1295 / Ipamorelin banned in sport?

Both components are prohibited under anti-doping codes.

Sources

  1. U.S. Food and Drug Administration — enforcement actions and warnings on unapproved peptide products.
  2. World Anti-Doping Agency (WADA) Prohibited List — current edition.
  3. Peer-reviewed preclinical and (where available) clinical literature, graded for evidence quality.

Spotted an error? Submit a correction.